Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners

Abstract

RIPK1 is a death-domain (DD) containing kinase involved in regulating apoptosis, necroptosis and inflammation. RIPK1 activation is known to be regulated by its DD-mediated interaction and ubiquitination, though underlying mechanisms remain incompletely understood. Here we show that K627 in human RIPK1-DD and its equivalent K612 in murine RIPK1-DD is a key ubiquitination site that regulates the overall ubiquitination pattern of RIPK1 and its DD-mediated interactions with other DD-containing proteins. K627R/K612R mutation inhibits the activation of RIPK1 and blocks both apoptosis and necroptosis mediated by TNFR1 signaling. However, Ripk1K612R/K612R mutation sensitizes cells to necroptosis and caspase-1 activation in response to TLRs signaling. Ripk1K612R/K612R mice are viable, but develop age-dependent reduction of RIPK1 expression, spontaneous intestinal inflammation and splenomegaly, which can be rescued by antibiotic treatment and partially by Ripk3 deficiency. Furthermore, we show that the interaction of RIPK1 with FADD contributes to suppressing the activation of RIPK3 mediated by TLRs signaling. Our study demonstrates the distinct roles of K612 ubiquitination in mRIPK1/K627 ubiquitination in hRIPK1 in regulating its pro-death kinase activity in response to TNFα and pro-survival activity in response to TLRs signaling.

The Identification of Candidate Biomarkers and Pathways in Atherosclerosis by Integrated Bioinformatics Analysis

“…Under the stimulation of TNF- α , TNFR1 was a powerful proinflammatory cytokine that participates in the occurrence of various inflammations and degenerative diseases [ 33 ]. RIPK1-DD-mediated dimerization was the key to promote the activation of RIPK1 during the process of tumor necrosis factor- α -stimulated cell transition from complex I to complex II [ 34 ]. In addition, the potential crucial genes need further validation by RT-qPCR in clinical samples.…”

Unlocking the Recovery Potential: JMJD3 Inhibition-Mediated SAPK/JNK Signaling Inactivation Supports Endogenous Oligodendrocyte-Lineage Commitment Post Mammalian Spinal Cord Injury

“…JMJD3 mediated H3K27me3 demethylation is a critical repressive epigenetic event, which exerts functions in multiple physiological and pathological processes [ 33 , 34 ]. Although previous study have shown that JMJD3 deeply involved in the neurogenesis and neurodegeneration of CNS, as cellular responses to SCI, the underlying epigenetic motivations of JMJD3 fluctuation still to be further investigated [ 34 , 35 ]. From the pathological gliogenesis perspective, the overwhelming majority of newly generated cells in response to SCI are reactive astrocytes [ 36 ].…”

Over Fifty Years of Life, Death, and Cannibalism: A Historical Recollection of Apoptosis and Autophagy

“…Additionally, RIPK1 regulates the extrinsic apoptosis pathway by interacting with the death domains of FADD and TRADD in DISC [153,158,174,175]. The effects of RIPK1 are further regulated via PTM through the NFκB-mediated pathway or independently of NFκB [176,177]. Recently, Smyth et al introduced FLIP(L) as a pseudocaspase, which has structural homology with caspases 8 and 10 in its C terminal; however, this homology domain in FLIP(L) lacks catalytic function.…”